TABLE 2.
Cohorts of HLA-A*02:01-positive, HSV-seropositive SYMP and ASYMP individuals enrolled in the studya
| Characteristic | Result for all subjects (n = 781) |
|---|---|
| No. (%) of subjects by gender | |
| Female | 395 (51) |
| Male | 386 (49) |
| No. (%) of subjects by race | |
| White | 543 (69) |
| Nonwhite | 238 (31) |
| Median (range) age (yr) | 30 (21–67) |
| No. (%) of subjects by HSV infection status | |
| HSV-1 positive | 283 (36) |
| HSV-2 positive | 366 (47) |
| HSV-1 and HSV-2 positive | 31 (4) |
| HSV negative | 92 (12) |
| No. (%) of subjects by HLA-A*02:01 status | |
| Positive | 411 (53) |
| Negative | 370 (44) |
| No. (%) of subjects by herpes disease status | |
| ASYMP | 711 (91) |
| SYMP | 70 (9) |
a
The definitions of SYMP and ASYMP individuals are detailed in Materials and Methods.